IL17A and cancer: Moreover, these targets were significantly enriched in many pathways related to cancer and immune function, not only were they involved in cytokine–cytokine receptor interaction, but also antifolate resistance, IL‐17 signaling pathway, NF‐kappa B signaling pathway, toll‐like receptor signaling pathway, and so on as well.